February 18, 2013

Company announcements: LATEXX, PHARMA, WCT-WB, WCT-WD, SYCAL

LATEXX - Changes in Sub. S-hldr's Int. (29B) - B & C Semperit Holding GmbH

Announcement Type: Changes in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965
Company NameLATEXX PARTNERS BERHAD  
Stock Name LATEXX  
Date Announced18 Feb 2013  
CategoryChanges in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965
Reference NoCG-130218-F4123

Particulars of substantial Securities Holder

NameB & C Semperit Holding GmbH
AddressUniversitatsring 14, 1010 Wien
NRIC/Passport No/Company No.FN 256.6676
Nationality/Country of incorporationIncorporated in Vienna,Austria
Descriptions (Class & nominal value)Ordinary Shares of RM0.50 each
Name & address of registered holderSemperit Investments Asia Pte Ltd
4, Battery Road, #25-01
Bank of China Building
Singapore 049908

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transactionDate of change
No of securities
Price Transacted (RM)
Acquired06/02/2013
184,000
 
Acquired07/02/2013
44,500
 
Acquired08/02/2013
99,200
 

Circumstances by reason of which change has occurredDeemed interest in the shares of Latexx Partners Berhad ("LPB") pursuant to Section 6A(4) of the Companies Act, 1965 by virtue of the acquisition in the open market by Semperit Investments Asia Pte Ltd ("SIA") of 327,700 ordinary shares of par value RM0.50 each in LPB. B & C Semperit Holding GmbH through its associate is the holder of more than 15% of the voting shares in SIA.
Nature of interestDeemed Interest
Direct (units)
Direct (%)
Indirect/deemed interest (units)185,665,498 
Indirect/deemed interest (%)83.38 
Total no of securities after change185,665,498
Date of notice15/02/2013


LATEXX - Changes in Sub. S-hldr's Int. (29B) - B & C Privatstiftung

Announcement Type: Changes in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965
Company NameLATEXX PARTNERS BERHAD  
Stock Name LATEXX  
Date Announced18 Feb 2013  
CategoryChanges in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965
Reference NoCG-130218-F4121

Particulars of substantial Securities Holder

NameB & C Privatstiftung
AddressUniversitatsring 14, 1010 Wien
NRIC/Passport No/Company No.FN 203.482p
Nationality/Country of incorporationIncorporated in Vienna,Austria
Descriptions (Class & nominal value)Ordinary Shares of RM0.50 each
Name & address of registered holderSemperit Investments Asia Pte Ltd
4, Battery Road, #25-01
Bank of China Building
Singapore 049908

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transactionDate of change
No of securities
Price Transacted (RM)
Acquired06/02/2013
184,000
 
Acquired07/02/2013
44,500
 
Acquired08/02/2013
99,200
 

Circumstances by reason of which change has occurredDeemed interest in the shares of Latexx Partners Berhad ("LPB") pursuant to Section 6A(4) of the Companies Act, 1965 by virtue of the acquisition in the open market by Semperit Investments Asia Pte Ltd ("SIA") of 327,700 ordinary shares of par value RM0.50 each in LPB. B & C Privatstiftung through its associate is the holder of more than 15% of the voting shares in SIA.
Nature of interestDeemed Interest
Direct (units)
Direct (%)
Indirect/deemed interest (units)185,665,498 
Indirect/deemed interest (%)83.38 
Total no of securities after change185,665,498
Date of notice15/02/2013


LATEXX - Changes in Sub. S-hldr's Int. (29B) - Semperit Investments Asia Pte Ltd

Announcement Type: Changes in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965
Company NameLATEXX PARTNERS BERHAD  
Stock Name LATEXX  
Date Announced18 Feb 2013  
CategoryChanges in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965
Reference NoCG-130218-F410E

Particulars of substantial Securities Holder

NameSemperit Investments Asia Pte Ltd
Address4, Battery Road, #25-01
Bank of China Building
Singapore 049908
NRIC/Passport No/Company No.201221964N
Nationality/Country of incorporationIncorporated in Singapore
Descriptions (Class & nominal value)Ordinary Shares of RM0.50 each
Name & address of registered holderSemperit Investments Asia Pte Ltd
4, Battery Road, #25-01
Bank of China Building
Singapore 049908

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transactionDate of change
No of securities
Price Transacted (RM)
Acquired06/02/2013
184,000
 
Acquired07/02/2013
44,500
 
Acquired08/02/2013
99,200
 

Circumstances by reason of which change has occurredAcquisition in the open market by Semperit Investments Asia Pte Ltd ("SIA") of 327,700 ordinary shares of par value RM0.50 each in Latexx Partners Berhad.
Nature of interestDirect Interest
Direct (units)185,665,498 
Direct (%)83.38 
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change185,665,498
Date of notice15/02/2013


PHARMA - Quarterly rpt on consolidated results for the financial period ended 31/12/2012

Announcement Type: Financial Results
Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA  
Date Announced18 Feb 2013  
CategoryFinancial Results
Reference NoPB-130206-32871

Financial Year End31/12/2012
Quarter4
Quarterly report for the financial period ended31/12/2012
The figureshave not been audited

Attachments

KLSE1212.pdf
256 KB


Remarks :
The Basic Earnings per Share ("EPS") for the preceding year corresponding quarter and period, and Net Assets per Share for the preceding financial year end have been restated to reflect the retrospective adjustments arising from the bonus issue which was completed on 20 February 2012 and adoption of Malaysian Financial Reporting Standards.
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2012

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2012
31/12/2011
31/12/2012
31/12/2011
$$'000
$$'000
$$'000
$$'000
1Revenue
482,404
367,786
1,812,346
1,520,981
2Profit/(loss) before tax
4,248
16,368
103,313
73,186
3Profit/(loss) for the period
-7,468
12,182
63,205
52,785
4Profit/(loss) attributable to ordinary equity holders of the parent
-7,934
11,942
61,710
52,157
5Basic earnings/(loss) per share (Subunit)
-6.74
10.15
52.44
44.32
6Proposed/Declared dividend per share (Subunit)
10.00
30.00
35.00
30.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
4.0100
3.9600
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence


PHARMA - Interim Dividend

Announcement Type: Entitlements (Notice of Book Closure)
Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA  
Date Announced18 Feb 2013  
CategoryEntitlements (Notice of Book Closure)
Reference NoPB-130206-32639

EX-date04/03/2013
Entitlement date06/03/2013
Entitlement time05:00:00 PM
Entitlement subjectInterim Dividend
Entitlement descriptionFourth Interim Dividend - Single Tier 10 sen
Period of interest payment to
Financial Year End31/12/2012
Share transfer book & register of members will be 06/03/2013 to 06/03/2013 closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone noTricor Investor Services Sdn Bhd
Level 17, The Gardens North Tower
Mid Valley City, Lingkaran Syed Putra
59200 Kuala Lumpur
Tel No. 03-22643883
Payment date 27/03/2013
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers06/03/2013 
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit 
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable) 
Entitlement indicatorCurrency
CurrencyMalaysian Ringgit (MYR)
Entitlement in Currency0.1


PHARMA - TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS):RECURRENT RELATED PARTY TRANSACTIONS

Announcement Type: General Announcement
Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA  
Date Announced18 Feb 2013  
CategoryGeneral Announcement
Reference NoPB-130131-42723

TypeAnnouncement
SubjectTRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
RECURRENT RELATED PARTY TRANSACTIONS
DescriptionPROPOSED RENEWAL OF SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE

The Board of Directors of Pharmaniaga Berhad ("the Company") wishes to inform that the Company will be seeking shareholders' approval in respect of the above proposals at the forthcoming Annual General Meeting.

The Circular setting out the details of the Proposals will be despatched to the shareholders in due course.

This announcement is dated 18 February 2013.



PHARMA - NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS):COMBINATION OF NEW ISSUE OF SECURITIES

Announcement Type: General Announcement
Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA  
Date Announced18 Feb 2013  
CategoryGeneral Announcement
Reference NoMI-130218-47799

TypeAnnouncement
SubjectNEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
COMBINATION OF NEW ISSUE OF SECURITIES
DescriptionPHARMANIAGA BERHAD (“PHARMANIAGA” OR “COMPANY”)

(I) PROPOSED SHARE SPLIT INVOLVING THE SUBDIVISION OF EVERY ONE (1) EXISTING ORDINARY SHARE OF RM1.00 EACH IN PHARMANIAGA (“PHARMANIAGA SHARE(S)”) INTO TWO (2) ORDINARY SHARES OF RM0.50 EACH IN PHARMANIAGA (“SUBDIVIDED SHARE(S)”) (“PROPOSED SHARE SPLIT”);

(II) PROPOSED BONUS ISSUE OF 23,534,794 NEW SUBDIVIDED SHARES (“BONUS SHARE(S)”) AFTER THE PROPOSED SHARE SPLIT ON THE BASIS OF ONE (1) BONUS SHARE FOR EVERY TEN (10) SUBDIVIDED SHARES HELD (“PROPOSED BONUS ISSUE”); AND

(III) PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION (“M&A”) OF PHARMANIAGA TO FACILITATE AND ALLOW FOR THE IMPLEMENTATION OF THE PROPOSED SHARE SPLIT (“PROPOSED AMENDMENTS”)

(COLLECTIVELY REFERRED TO AS THE “PROPOSALS”)

On behalf of the Board of Directors of Pharmaniaga (“Board”), AFFIN Investment Bank Berhad (“AFFIN Investment”) wishes to announce that the Company proposes to undertake the following exercises:

(i) Proposed Share Split;

(ii) Proposed Bonus Issue; and

(iii) Proposed Amendments.

Further details on the Proposals are set out in the attachment enclosed.

This announcement is dated 18 February 2013.

Attachments

Proposals.pdf
233 KB



WCT-WB - Changes in Director's Interest (S135) - Choe Kai Keong

Announcement Type: Changes in Director's Interest Pursuant to Section 135 of the Companies Act. 1965
Company NameWCT BERHAD  
Stock Name WCT-WB  
Date Announced18 Feb 2013  
CategoryChanges in Director's Interest Pursuant to Section 135 of the Companies Act. 1965
Reference NoWW-130218-32336

Information Compiled By KLSE

Particulars of Director

NameChoe Kai Keong
AddressNo. 6, Jalan 13/10B, Seksyen 13, 40100 Shah Alam, Selangor Darul Ehsan
Descriptions(Class & nominal value)Warrants (2008/2013)

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction
Date of change
No of securities
Price Transacted (RM)
Disposed
15/02/2013
410,000
0.345 

Circumstances by reason of which change has occurredDisposal of warrants in the open market
Nature of interestDirect
Consideration (if any) 

Total no of securities after change

Direct (units)116,400 
Direct (%)0.12 
Indirect/deemed interest (units) 
Indirect/deemed interest (%) 
Date of notice18/02/2013


WCT-WD - Changes in Director's Interest (S135) - Choe Kai Keong

Announcement Type: Changes in Director's Interest Pursuant to Section 135 of the Companies Act. 1965
Company NameWCT BERHAD  
Stock Name WCT-WD  
Date Announced18 Feb 2013  
CategoryChanges in Director's Interest Pursuant to Section 135 of the Companies Act. 1965
Reference NoWW-130218-5FCCC

Information Compiled By KLSE

Particulars of Director

NameChoe Kai Keong
AddressNo. 6, Jalan 13/10B, Seksyen 13, 40100 Shah Alam, Selangor Darul Ehsan
Descriptions(Class & nominal value)Warrants (2012/2017)

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction
Date of change
No of securities
Price Transacted (RM)
Acquired
15/02/2013
410,000
0.306 

Circumstances by reason of which change has occurredAcquisition of warrants in the open market
Nature of interestDirect
Consideration (if any) 

Total no of securities after change

Direct (units)907,262 
Direct (%)0.55 
Indirect/deemed interest (units) 
Indirect/deemed interest (%) 
Date of notice18/02/2013


SYCAL - Changes in Director's Interest (S135) - Dato' Seow Yong Chin

Announcement Type: Changes in Director's Interest Pursuant to Section 135 of the Companies Act. 1965
Company NameSYCAL VENTURES BERHAD  
Stock Name SYCAL  
Date Announced18 Feb 2013  
CategoryChanges in Director's Interest Pursuant to Section 135 of the Companies Act. 1965
Reference NoSV-130218-C5A4F

Information Compiled By KLSE

Particulars of Director

NameDato' Seow Yong Chin
Address55, Jalan Nyaman 4, Happy Garden, Jalan Kelang Lama,
58200 Kuala Lumpur
Descriptions(Class & nominal value)Ordinary shares of RM1.00 each

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction
Date of change
No of securities
Price Transacted (RM)
Acquired
15/02/2013
250,070
0.000 

Circumstances by reason of which change has occurredoff market acquisition of shares by SYC Holdings Sdn Bhd
Nature of interestIndirect
Consideration (if any)cash 

Total no of securities after change

Direct (units)18,826,145 
Direct (%)5.88 
Indirect/deemed interest (units)32,853,291 
Indirect/deemed interest (%)10.26 
Date of notice18/02/2013

Remarks :
Deemed interest through his equity interests in Cygal Holdings Sdn Bhd. and SYC Holdings Sdn Bhd


No comments:

Post a Comment